The molecular portraits of breast tumors are conserved across microarray platforms.
about
The CD44+/CD24- phenotype is enriched in basal-like breast tumorsSuppression of breast tumor growth and metastasis by an engineered transcription factorMolecular profiling of patient-derived breast cancer xenograftsNottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inferenceZNF703 gene amplification at 8p12 specifies luminal B breast cancerTargeting androgen receptor in estrogen receptor-negative breast cancerGenomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsBreast cancer in the personal genomics eraThe transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypesTumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesLung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell typesIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerMicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeActivation of host wound responses in breast cancer microenvironmentMaintaining Genome Stability in Defiance of Mitotic DNA DamageCancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesTargeted therapies with companion diagnostics in the management of breast cancer: current perspectivesBreast cancer intrinsic subtype classification, clinical use and future trendsTriple negative breast cancer: looking for the missing link between biology and treatmentsTargeting triple-negative breast cancer: optimising therapeutic outcomesBiological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferationBreast cancer molecular subtypes: from TNBC to QNBCHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerReconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancerThe MINDACT trial: the first prospective clinical validation of a genomic toolPerceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal StudyUnraveling the microenvironmental influences on the normal mammary gland and breast cancerA gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patientsDistinct genes related to drug response identified in ER positive and ER negative breast cancer cell linesAcidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian developmentBDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression?miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsGene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissueCharacterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsA gene expression signature predicts survival of patients with stage I non-small cell lung cancerAn embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumorsSupervised risk predictor of breast cancer based on intrinsic subtypesIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
P2860
Q21092906-2B1497CC-EC05-4143-92D8-B5CC55BEAAD0Q21135222-48949064-3363-44C0-94DF-DF212DB3392AQ21195204-20AB629B-3905-409F-8F97-F5AB3185FD85Q21261291-AD4FA710-CDCF-4C8F-A5BF-95C57D420DABQ21284334-F6C01279-B8C5-4E37-964D-89AC646FB818Q24293333-5F553275-C61D-40C5-ACAA-9F5CA9604161Q24312457-22BEED74-645D-4174-A1FE-D33184BBD748Q24595882-175A0CD0-8D0A-41F8-BE1D-5192BC9C9803Q24602679-5CE746F4-45B3-44FC-8FD8-E94EDB39ACBCQ24617123-C1C14EA8-8365-4B04-A607-3FC99D9224B9Q24630783-26F74AAD-234B-4260-96B7-B344C7CCF7B2Q24632760-8E04E186-8B7C-4AFB-A1F8-FD25E7342032Q24633201-F5CE4F91-53BD-450C-A37A-44091FCB6DECQ24646090-CA861CA9-3B3D-4382-BB91-BB9695A6B16AQ24650013-5B30F83E-87C9-4E08-AD0F-9868E83B1922Q26738970-D40FF320-0D68-49C0-9436-ACE13512195CQ26743510-6D4FC1B4-2E71-4C47-B99B-FD77DD331DF2Q26768119-6A00AB92-19C1-429C-9378-34996A7DE171Q26773761-9423E32B-F251-4AC7-BF1F-FE0D929E9A6DQ26783122-C8296337-E1F1-4F74-BB2A-D4A4279C10D1Q26850892-23D0D1EF-E8DC-415F-9346-5FA5DC33C66BQ27311085-EF107116-1979-4906-8248-A494B6D38650Q27322396-2EA79B52-2E7A-48C6-A801-01BA6CCB70EAQ28076805-1D478EF3-EB61-44F1-84B8-1336A3140EE5Q28085413-A75FAA95-54BB-4927-B8A1-5A577FE7E20AQ28114915-1AA0F339-C2E0-448C-9FF4-14FB394C60C8Q28242008-8D04A39E-B3CF-472E-B932-E208D358F6E2Q28383479-92ECCB17-E6DA-4532-A97D-1FCF8FB9C872Q28473677-90804129-B965-4DBD-9168-C1FDD57FE005Q28477202-E4D8080C-3318-458E-92F6-DA2FC856988BQ28481323-45967598-29EB-42B5-83C2-C16AEBD07090Q28508982-1FF5EB4C-3644-4BD2-8BB3-3F2A738B9B58Q28540922-4B7A52FA-676D-4FE4-8062-17FFAC8309BFQ28742532-7C9671BD-70BE-4E79-A4AD-DBF87FBD3256Q28742831-03D733B3-5CC7-4E2F-9DE5-C5E811B337ACQ28751743-3D9D2712-EF7F-4B2F-B9F3-F8622C1146C2Q28764568-4E8E2ECB-CB60-43D9-A082-E2560C8B7955Q29615393-E7011D7A-FED5-426D-954B-412E2F0DA3C1Q29617404-8133F042-2899-472B-BC00-DD12FD9B61AFQ29617680-901327D8-EEB6-4EF8-9889-B0C56646A1FF
P2860
The molecular portraits of breast tumors are conserved across microarray platforms.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The molecular portraits of breast tumors are conserved across microarray platforms.
@ast
The molecular portraits of breast tumors are conserved across microarray platforms.
@en
type
label
The molecular portraits of breast tumors are conserved across microarray platforms.
@ast
The molecular portraits of breast tumors are conserved across microarray platforms.
@en
prefLabel
The molecular portraits of breast tumors are conserved across microarray platforms.
@ast
The molecular portraits of breast tumors are conserved across microarray platforms.
@en
P2093
P2860
P50
P356
P1433
P1476
The molecular portraits of breast tumors are conserved across microarray platforms.
@en
P2093
Alejandra Ruiz Orrico
Andrew Nobel
Bahjat F Qaqish
Chad Livasy
Daniel S Oh
Donna Dreher
Evangeline Reynolds
Heidi Hansen
J S Marron
P2860
P2888
P356
10.1186/1471-2164-7-96
P407
P577
2006-04-27T00:00:00Z
P5875
P6179
1015725266